Review
Published on 14 Apr 2023
Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1135350
- 3,491 views
- 2 citations
Type at least 3 characters
1,748 articles
Articles
Review
Published on 14 Apr 2023
Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1141108
- 18,471 views
- 23 citations
Review
Published on 12 Apr 2023
Long-term health outcomes of allogeneic hematopoietic stem cell transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1175794
- 3,878 views
- 4 citations
Case Report
Published on 11 Apr 2023
Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1095154
- 2,315 views
- 1 citation
Original Research
Published on 11 Apr 2023
Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1043694
- 2,130 views
- 1 citation
Review
Published on 06 Apr 2023
Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1128533
- 3,939 views
- 3 citations
Review
Published on 06 Apr 2023
An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1135812
- 6,523 views
- 3 citations
Editorial
Published on 05 Apr 2023
Editorial: The latest advances in transplantation for AML
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1189554
- 1,020 views
Review
Published on 05 Apr 2023
Dose optimization strategy of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib for chronic myeloid leukemia: From clinical trials to real-life settings
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1146108
- 4,640 views
- 5 citations
Case Report
Published on 31 Mar 2023
Fluid overload–associated large B-cell lymphoma with primary biliary cirrhosis: A case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1145540
- 3,506 views
- 2 citations
Original Research
Published on 30 Mar 2023
A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1144403
- 2,205 views
Systematic Review
Published on 30 Mar 2023
Prognostic and clinicopathological role of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: A meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1169749
- 1,418 views
- 1 citation
Case Report
Published on 29 Mar 2023
Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1145376
- 1,803 views
Original Research
Published on 29 Mar 2023
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1157610
- 1,932 views
- 3 citations
Original Research
Published on 28 Mar 2023
A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1104425
- 2,452 views
- 2 citations
Original Research
Published on 28 Mar 2023
Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.998014
- 1,956 views
- 2 citations